Stallergenes to Drop Former Nestlé Peanut Allergy Pill Palforzia
The owner of the peanut allergy treatment Palforzia will abandon it less than three years after buying it from Nestlé, underscoring the disappointment of a product once billed as a...
By Lisa Pham, Fabienne Kinzelmann · Bloomberg
The owner of the peanut allergy treatment Palforzia will abandon it less than three years after buying it from Nestlé, underscoring the disappointment of a product once billed as a potential blockbuster.